» Articles » PMID: 30350019

Clostridium Difficile Infection in the USA: Incidence and Associated Factors in Revision Total Knee Arthroplasty Patients

Overview
Specialty Orthopedics
Date 2018 Oct 24
PMID 30350019
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Revision total knee arthroplasty (TKA) procedures performed secondary to periprosthetic joint infection (PJI) are associated with significant morbidity and mortality. These poor outcomes may be further complicated by postoperative infection requiring antibiotics. However, antibiotic overuse may suppress patients' bacterial flora, leading to Clostridium difficile infection (CDI). Therefore, we aimed to study the: (1) incidence; (2) costs; and (3) risk factors associated with CDI in revision TKA patients.

Methods: The National Inpatient Sample database was queried for individuals diagnosed with PJI who underwent revision TKA between 2009 and 2013 (n = 83,806). Patients who developed CDI during their inpatient stay were identified (n = 799). Logistic regression analysis was conducted to assess the association between hospital- and patient-specific characteristics and the development of CDI.

Results: The incidence of CDI after revision TKA was 1.0%. These patients were older (mean age 69.05 vs. 65.52 years), had greater LOS (median 11 vs. 5 days) and greater costs ($30,612.93 vs. 18,873.75), and experienced higher in-hospital mortality (3.6 vs. 0.5%; p < 0.001 for all) compared to those without infection. Patients with CDI were more likely to be treated in urban, not-for-profit, medium/large hospitals in the Northeast or Midwest (p < 0.05 for all) and to have underlying depression (OR 4.267; p = 0.007) or fluid/electrolyte disorders (OR 3.48; p = 0.001).

Conclusion: Although CDI is rare following revision TKA, it can have detrimental consequences. We demonstrate that CDI is associated with longer LOS, higher costs, and greater in-hospital mortality. With increased legislative pressure to lower healthcare expenditures, it is crucial to identify means of preventing costly complications.

Citing Articles

What's New in Musculoskeletal Infection.

Fehring T, Fehring K, Hewlett A, Higuera C, Otero J, Tande A J Bone Joint Surg Am. 2020; 102(14):1222-1229.

PMID: 32675671 PMC: 7431136. DOI: 10.2106/JBJS.20.00363.


Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis.

Marra A, Perencevich E, Nelson R, Samore M, Khader K, Chiang H JAMA Netw Open. 2020; 3(1):e1917597.

PMID: 31913488 PMC: 6991241. DOI: 10.1001/jamanetworkopen.2019.17597.


Prosthesis design of animal models of periprosthetic joint infection following total knee arthroplasty: A systematic review.

Jie K, Deng P, Cao H, Feng W, Chen J, Zeng Y PLoS One. 2019; 14(10):e0223402.

PMID: 31581252 PMC: 6776332. DOI: 10.1371/journal.pone.0223402.

References
1.
Aggarwal V, Rasouli M, Parvizi J . Periprosthetic joint infection: Current concept. Indian J Orthop. 2013; 47(1):10-7. PMC: 3601222. DOI: 10.4103/0019-5413.106884. View

2.
Rogers M, Greene M, Young V, Saint S, Langa K, Kao J . Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med. 2013; 11:121. PMC: 3651296. DOI: 10.1186/1741-7015-11-121. View

3.
Mazzucchelli L, Rosso F, Marmotti A, Bonasia D, Bruzzone M, Rossi R . The use of spacers (static and mobile) in infection knee arthroplasty. Curr Rev Musculoskelet Med. 2015; 8(4):373-82. PMC: 4630232. DOI: 10.1007/s12178-015-9293-8. View

4.
Abdelsattar Z, Krapohl G, Alrahmani L, Banerjee M, Krell R, Wong S . Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol. 2015; 36(1):40-6. PMC: 4597881. DOI: 10.1017/ice.2014.8. View

5.
Stevens V, Dumyati G, Fine L, Fisher S, van Wijngaarden E . Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis. 2011; 53(1):42-8. DOI: 10.1093/cid/cir301. View